Articles dans des revues avec comité de lecture (5)
1.
Ali, H., Jakub, W., Bendoumou, M., Heng-Chang, C., Maiuri, P., Dutilleul, A., Selberg, S., Nestola, L., Kamil, L., Avettand-Fenoël, V., Necsoi, C., Marcello, A., Esko, K., Mati, K., De Wit, S., Pyrc, K., Pasternak, A. O., Van Lint, C., & Kula-Pacurar, A. (2025). Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency. Virology journal,(22), 124.2.
Dorman, A., Bendoumou, M., Valaitienė, A., Jakub, W., Ali, H., Dutilleul, A., Maiuri, P., Nestola, L., Bociaga-Jasik, M., Mchantaf, G., Necsoi, C., De Wit, S., Avettand-Fenoël, V., Marcello, A., Pyrc, K., Pasternak, A., Van Lint, C., & Kula-Pacurar, A. (2025). Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in viral latency (A. Pasternak, C. Van Lint and A. Kula-Pacurar are co-corresponding and co-senior authors). Nature communications.3.
Dias, J., Cattin, A., Bendoumou, M., Dutilleul, A., Lodge, R., Goulet, J.-P., Fert, A., Raymond Marchand, L., Wiche Salinas, T. R., Ngassaki-Yoka, C.-D., Gabriel, E. M., Caballero, R. E., Routy, J.-P., Cohen, É. A., Van Lint, C., & Ancuta, P. (2024). Retinoic acid enhances HIV-1 reverse transcription and transcription in macrophages via mTOR-modulated mechanisms (C. Van Lint and P. Ancuta are co-corresponding authors). Cell reports, 43(7), 114414. doi:10.1016/j.celrep.2024.1144144.
Chatterjee, D., Zhang, Y., Ngassaki-Yoka, C.-D., Dutilleul, A., Khalil, S., Hernalsteens, O., Wiche Salinas, T. R., Dias, J., Huicheng, C., Smail, Y., Goulet, J.-P., Brendan, B., Routy, J.-P., Van Lint, C., & Ancuta, P. (2023). Identification of Aryl Hydrocarbon Receptor as a Barrier to HIV-1 Infection and Outgrowth in CD4+ T-Cells (C. Van Lint and P. Ancuta are co-corresponding authors). Cell reports, 42(6), doi:10.1016/j.celrep.2023.112634, 112634. doi:10.1016/j.celrep.2023.112634 Participations à des congrès et colloques internationaux (34)
1.
Santangelo, M., Bendoumou, M., Dutilleul, A., Khalfi, S., Ngassaki Yoka, C. D., Nestola, L., Dieu, M., Renard, P., Ancuta, P., & Van Lint, C. (2026). Identification of the cellular transcription factor KLF16 as a new HIV-1 silencing factor. Poster présenté à la conférence Conference on Retroviruses and Opportunistic infections (CROI) (22-25 February 2026: Denver (Colorado)).2.
Bendoumou, M., Pilosio, L., Dutilleul, A., Nestola, L., Ait-Ammar, A., & Van Lint, C. (2026). UHRF1 regulates multiple layers of HIV-1 expression, from epigenetics to post-transcriptional events. Poster présenté à la conférence Conference on Retroviruses and Opportunistic infections (CROI) (22-25 February 2026: Denver (Colorado)).3.
Bendoumou, M., Dutilleul, A., Nestola, L., Paiardini, M., Kulpa, D., Silvestri, G., & Van Lint, C. (2026). Molecular mechanisms of the CD8+ T cell-mediated non-cytolytic silencing of HIV-1 transcription. Poster présenté à la conférence Conference on Retroviruses and Opportunistic infections (CROI) (22-25 February 2026: Denver (Colorado)).4.
Dorman, A., Bendoumou, M., Valaitienė, A., Wadas, J., Ali, H., Dutilleul, A., Maiuri, P., Nestola, L., Bociaga-Jasik, M., Mchantaf, G., Necsoi, C., De Wit, S., Avettand-Fenoël, V., Marcello, A., Pyrc, K., Pasternak, A. O., Van Lint, C., & Kula-Pacurar, A. (2025). Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Paper session presented at 13th Breach Symposium (Palais des Académies: 27/11/2025: Brussels).5.
Bendoumou, M., Pilosio, L., Dutilleul, A., Nestola, L., Ait-Ammar, A., & Van Lint, C. (2025). From epigenetics to post-transcriptional events : How UHRF1 orchestrates multiple layers of HIV-1 gene expression. Paper session presented at 13th Palais des Académies (27/11/2025: Brussels, Palais des Académies).6.
Marray, T., Hernalsteens, O., Verdikt, R., Dutilleul, A., Vanhulle, C., Nestola, L., Bendoumou, M., Santangelo, M., & Van Lint, C. (2025). Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells. Poster présenté à la conférence The 2nd international Meeting on Epigenetics & Epigenomics in health and diseases (September 24-26, 2025: Brussels, Belgium).